Back to Newsroom

PTC Therapeutics Recognizes World Duchenne Awareness Day by Announcing Winners of Global Duchenne Muscular Dystrophy Patient Group Awards and Expanding Disease State Awareness Website

SOUTH PLAINFIELD, N.J., Sept. 7, 2016 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) is pleased to announce the recipients of the Company’s 2016 global STRIVE Awards (Strategies to Realize Innovation, Vision and Empowerment) program, designed to support nonprofit organizations serving the Duchenne muscular dystrophy (DMD) community. The announcement is made as the international DMD community marks World Duchenne Awareness Day.

Click here to read the full release